Form D · Biotechnology
BioCircuit Technologies, Inc.
Atlanta, GA · CIK 0001777259
Offering snapshot reported Oct 3, 2022 · SEC filing
- Reported sold
- $9M Offering amount: $9M
- Investors reported
- 33 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 20, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 3, 2022 | Initial | $9,000,000 | No comparison | 33 | SEC filing |
| Apr 23, 2021 | Initial | $3,150,000 | No comparison | 13 | SEC filing |
| Apr 23, 2021 | Initial | $1,500,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 04, 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-460515
Convertible Notes
Source: Form D, filed Oct 3, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michelle Jarrard | Director, Executive |
| Michael Masters | Director |
| James Nahirny | Director |
| Thomas O'brien | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1819 Peachtree Road N.E. Suite 205
Atlanta, GA, 30309
Atlanta, GA, 30309